FibroScan® by echosens
The non-invasive solution for comprehensive management of liver health
Cirrhosis is a leading cause of mortality worldwide.
Identifying cirrhosis early in patients helps to proactively manage the disease through screenings for liver-related complications such as hepatocellular carcinoma and esophageal varices.
Agile 4 combines LSM by VCTE™ with easily accessible blood biomarkers (AST, ALT, Platelets) to help in the identification of cirrhosis in NAFLD patients to properly identify patients to start HCC and portal hypertension screening.
Formula
High clinical performances demonstrated in large external validation cohorts from different geographical origins.
Peer reviewed paper under submission
Sanyal et al., Enhanced diagnosis of advanced fibrosis and cirrhosis in non-alcoholic fatty liver disease patients with FibroScan®-based Agile scores.
Agile 3+ calculator is a tool for clinicians, computed from LSM (obtained from FibroScan® device), AST, ALT, platelets, diabetes status, age and gender, to aid in the identification of patients with suspicion of NAFLD as having advanced fibrosis.
The non-invasive solution for comprehensive management of liver health
Enhance FibroScan® liver disease assessment with biological markers
Your everyday FibroScan® companion – free application
Optimize clinical workflows with real-time secure data transmission